Videos
Femtech in the Spotlight — An Interview with Wolfgang Hackl — Founder and CEO of OncoGenomX
July 11, 2022
Eva von Mühlenen (Advisor, Geneva) and Josefine Sommer (Senior Managing Associate, Brussels) interviewed Wolfgang Hackl, founder of OncoGenomX, a Femtech startup that guides doctors in the treatment of breast cancer — about regulation, research and development (R&D), and the vast potential of artificial intelligence in the field of health technology for women.
Contacts
Related Resources
Related Blogs
Capabilities
Related Pages
Suggested News & Insights
Recharge & Recaffeinate With Sidley @ JPMMonday, January 11, 2027 – Tuesday, January 12, 2027GMP 2026: Regulatory Reliance, AI, and the Future of Pharmaceutical ManufacturingWednesday, December 2, 2026A New World Order – Market Access, MFN, and GeopoliticsTuesday, November 10, 2026FDA Finalizes New Dietary Ingredient Guidance, but Questions RemainOctober 23, 2026Sidley & Trinity Capital Life Sciences ReceptionThursday, October 22, 2026Revised EU Product Liability Directive: The Long Read — Scope, Key Changes, and Compliance Implications for Businesses (Part 1)October 21, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory